Synchronous occurrence of primary neoplasms of the uterus with mucinous carcinoma of the cervix and endometrioid carcinoma of the endometrium  by Sun, Hsu-Dong et al.
Available online at www.sciencedirect.comTaiwanese Journal of Obstetrics & Gynecology 50 (2011) 377e378
www.tjog-online.comResearch Letter
Synchronous occurrence of primary neoplasms of the uterus with mucinous
carcinoma of the cervix and endometrioid carcinoma of the endometrium
Hsu-Dong Sun a,b, Chung-Ru Lai c, Ming-Shyen Yen b, Peng-Hui Wang b,d,*
aDepartment of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Ban Ciao, New Taipei City, Taiwan
bDepartment of Obstetrics and Gynecology, Taipei Veterans General Hospital, and National Yang-Ming University School of Medicine, Taipei, Taiwan
cDepartment of Pathology, Taipei Veterans General Hospital, and National Yang-Ming University School of Medicine, Taipei, Taiwan
dDepartment of Obstetrics and Gynecology, National Yang-Ming University Hospital, Ilan, Taiwan
Accepted 3 March 2010Two primary gynecological cancers are occasionally found,
and most are a combination of ovarian and endometrial
cancers. Synchronous primary malignancies of the uterus
located on the cervix and endometrium are extremely rare.
Therefore, the treatment and outcome of these patients are still
uncertain. A case of combined adenocarcinoma of the cervix
and endometrium is reported.
A 55-year-old female presented at our hospital because of
postmenopausal bleeding. Pelvic examination and Pap smear
were unremarkable. Transvaginal ultrasound showed a 14-mm
thick endometrium. Diagnostic dilatation and curettage was
performed with a pathologic diagnosis of endometrioid carci-
noma, Grade 2 (Fig. 1). Therefore, she underwent laparotomy
staging surgery, including total hysterectomy, bilateral sal-
pingo-oophorectomy, and pelvic and para-aortic lymph node
sampling. The final pathology confirmed the preoperative
diagnosis [surgicopathological International Federation of
Gynecology and Obstetrics Stage: IB (1988 revision), Grade 2,
endometrioid carcinoma of the endometrium] (Fig. 2), but
showed co-existence of cervical cancer [mucinous carcinoma
of the cervix, 4.2 cm, with deep stromal and corpus invasion
(International Federation of Gynecology and Obstetrics Stage
IB2)] (Fig. 3). Because of the inadequacy of initial treatment
for this patient with cervical cancer, a postoperative adjuvant
therapydconcurrent chemoradiation, including external beam
pelvic radiation of 5040 cGy/28 fractions and five-course
weekly cisplatin (50 mg/m2) chemotherapy was used as
a rescue therapy. After complete treatment, she was free of
disease for 2 years.
Multiple primary malignancies in a single patient have
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organs is only 1e6% of all genital neoplasms [1]. The lesions
can be limited to a single organ or may involve multiple organ
systems. These lesions can be classified into 2 categories:
(1) synchronousdin which the cancers occur or are diagnosed
at the same time (a current case) or within 2 months and
(2) metachronousdin which the cancers follow in sequence
(more than 2 months apart) [1].
The etiology and pathogenesis of synchronous cancers
remain unclear. Eisner et al [2] speculated that when similar
tissues of the female genital tract in embryology are subjected to
carcinogens or irritants, they may develop synchronous tumors.
In addition to external carcinogens, an intrinsic susceptibility
may influence the risk of developing a second primary tumor in
patients with head and neck squamous cell carcinoma [3].
Several investigators have found that patients with endometrialFig. 1. The specimen derived from diagnostic dilatation and curettage showing
endometrioid carcinoma, Grade 2 (hematoxylin and eosin staining 100).
cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 2. Histology of the gross specimen (endometrial part) showing endome-
trioid carcinoma, Grade 2, with superficial invasion [International Federation
of Gynecology and Obstetrics (FIGO) 2009 revision: Stage 1A; FIGO 1988
revision: Stage 1B] (hematoxylin and eosin staining 40).
Fig. 3. Histology of the gross specimen (cervical part) showing mucinous
carcinoma with mucin secretion, with the entire layer invaded (International
Federation of Gynecology and Obstetrics: Stage IB2) (hematoxylin and
eosin 200).
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developing ovarian and cervical malignancy than the general
population [4]. The genetic defect of a mismatch repair defi-
ciency may be responsible for a small subset of double cancers
of the colon-rectum and stomach [5]. Mutation of p53, a tumor
suppressor gene, was identified in children and young adults
with a second malignant neoplasm [5].
Coexisting ovarian and endometrial cancers are the most
common synchronous gynecologic tumors in female patients
[6]. Only four patients were diagnosed with synchronous
endometrial and cervical cancer in Eisner’s series [2]. However,
all were a squamous cell carcinoma type of the cervix. The
prognosis of synchronous tumors is often considered worse
when compared with malignancies of a metachronous nature
[2], despite some encouraging individual results [1]. Ayhan et al
[6] reviewed the outcomes of patients with synchronous endo-
metrial and ovarian cancer as well as other different synchro-
nous tumors. They found that the survival of the patients is
related directly to the original disease stage of either of the two
cancers at the time of diagnosis. Early implementation of an
aggressive treatment strategy for both primary cancers will
provide a better outcome.
Treatment strategies in cases of synchronous cancers depend
on themore severe ormore advanced cancer and sometimes bothtumors can be treated simultaneously. Although this patient’s
true diagnosis was missed in the preoperative diagnosis and she
failed to receive an appropriate original therapeutic regimen, an
intensive, immediate, and aggressive treatment provided a good
outcome.
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